CD200 and infection: According to our results patients with CD200 rs1131199 GG genotype may be ideal candidates for inclusion in clinical trials exploring immune-based therapies, to analyze the clinical impact of combined immunotherapies with the aim of decreasing the early mortality due to infections and to progression of the disease.